For the Inventor, By the Inventor

Enter assignee name

Rhone Merieux

USPTO Granted Patents = 27

Trademarks = 7

Forward Citations = 274

Loading Chart...

Loading Chart...

67 inventors (with patents filed for the assignee):

Louis Joseph Ross (4 out of 8 patents)

Matthew M Binns (4 out of 16 patents)

Simon David Scott (4 out of 5 patents)

4. Raphael Jean Darteil (3 out of 7 patents)

5. Jean-Jacques Pin (2 out of 3 patents)

6. Raymond E Hopponen (2 out of 4 patents)

7. Lowell R Macy (2 out of 4 patents)

8. Michel Albert Riviere (2 out of 23 patents)

9. Carole Veronique Duinat (2 out of 3 patents)

10. Eliane Louise Laplace (2 out of 5 patents)

11. Michel Joseph Bublot (2 out of 28 patents)

12. Corine Martine LeComte (2 out of 2 patents)

13. Danielle Marie Vandenbergh (2 out of 2 patents)

14. Gilles-Emile Chappuis (2 out of 2 patents)

15. Joris Frans Vandeputte (2 out of 2 patents)

Core Competencies:

Viral Vaccines

Feline Infectious Peritonitis

Swine Dysentery

Avian Herpesvirus

N-Phenylpyrazole

Babesia Divergens

Melarsomine Dihydrochloride

Microspheres

Erythromycin Solutions

Peptide Fractions

Probes for Pestiviruses

LHRH Release

27 patents: Sort by Forward Citations

1. 6235282 - Vaccinal fluid water-in-oil emulsions containing a metabolizable oil (2001-05-22),

2. 6080850 - Feline infectious peritonitis vaccine (2000-06-27),

3. 5980906 - Live recombinant avian vaccine using an avian herpesvirus as vector (1999-11-09),

4. 5958425 - Viral vaccines (1999-09-28),

5. 5885607 - N-phenylpyrazole-based anti-flea and anti-tick external device for cats (1999-03-23),

6. 5884583 - Field bag boost vaccination delivery system (1999-03-23),

7. 5840574 - Viral vaccines (1998-11-24),

8. 5770733 - Medicinal products and pure preparations of melarsomine dihydrochloride, (1998-06-23),

9. 5750118 - Vaccine method against swine dysentery (1998-05-12),

10. 5747063 - Therapeutic elements for the oral administration of medication to (1998-05-05),

11. 5744143 - Viral vaccines (1998-04-28),

12. 5733554 - Avian herpesvirus-based live recombinant avian vaccine, in particular (1998-03-31),

13. 5723447 - Water miscible erythromycin solutions (1998-03-03),

14. 5665534 - Method of detecting bovine diarrhoea virus infection, nucleotide (1997-09-09),

15. 5648466 - Method for detecting bovine diarrhoea virus infection, nucleotide (1997-07-15),

Company Overview

Rhone Merieux is a prominent player in the biotechnology sector, specializing in the development and manufacturing of innovative solutions for the healthcare industry. The company focuses on diagnostics, vaccines, and biopharmaceuticals, contributing to advancements in disease prevention and treatment. With a strong emphasis on research and development, Rhone Merieux leverages cutting-edge technologies to enhance public health outcomes, primarily serving markets in Europe and beyond from its headquarters in Lyon, France.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

27 Patents

#19 in Lyon

#788 in France

#24,012 in the World

Rhone Merieux

Forward Citations = 274

67 inventors:

Louis Joseph Ross (4 out of 8 patents)

Matthew M Binns (4 out of 16 patents)

Simon David Scott (4 out of 5 patents)

4. Raphael Jean Darteil (3 out of 7 patents)

5. Jean-Jacques Pin (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Rhone Merieux. Retrieved from https://idiyas.com/company/rhone-merieux

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…